Harmony Biosciences (HRMY) Competitors $37.22 +0.53 (+1.44%) Closing price 04:00 PM EasternExtended Trading$36.68 -0.54 (-1.45%) As of 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HRMY vs. ROIV, LEGN, ELAN, RGC, RVMD, GRFS, TGTX, NUVL, CRSP, and RYTMShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Roivant Sciences (ROIV), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Regencell Bioscience (RGC), Revolution Medicines (RVMD), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), CRISPR Therapeutics (CRSP), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "pharmaceutical products" industry. Harmony Biosciences vs. Its Competitors Roivant Sciences Legend Biotech Elanco Animal Health Regencell Bioscience Revolution Medicines Grifols TG Therapeutics Nuvalent CRISPR Therapeutics Rhythm Pharmaceuticals Harmony Biosciences (NASDAQ:HRMY) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends. Does the media refer more to HRMY or ROIV? In the previous week, Harmony Biosciences had 13 more articles in the media than Roivant Sciences. MarketBeat recorded 14 mentions for Harmony Biosciences and 1 mentions for Roivant Sciences. Roivant Sciences' average media sentiment score of 1.63 beat Harmony Biosciences' score of 1.14 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harmony Biosciences 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals have more ownership in HRMY or ROIV? 86.2% of Harmony Biosciences shares are owned by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are owned by institutional investors. 23.6% of Harmony Biosciences shares are owned by company insiders. Comparatively, 7.9% of Roivant Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts rate HRMY or ROIV? Harmony Biosciences presently has a consensus target price of $51.00, suggesting a potential upside of 37.02%. Roivant Sciences has a consensus target price of $16.50, suggesting a potential upside of 44.86%. Given Roivant Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Roivant Sciences is more favorable than Harmony Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harmony Biosciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.25 Which has more volatility & risk, HRMY or ROIV? Harmony Biosciences has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Is HRMY or ROIV more profitable? Harmony Biosciences has a net margin of 20.53% compared to Roivant Sciences' net margin of -225.71%. Harmony Biosciences' return on equity of 24.32% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Harmony Biosciences20.53% 24.32% 15.92% Roivant Sciences -225.71%-14.76%-13.69% Which has higher earnings & valuation, HRMY or ROIV? Harmony Biosciences has higher revenue and earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarmony Biosciences$744.85M2.87$145.49M$2.6214.21Roivant Sciences$29.05M266.54-$171.98M-$0.25-45.56 SummaryHarmony Biosciences beats Roivant Sciences on 11 of the 17 factors compared between the two stocks. Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HRMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.14B$3.04B$5.66B$9.45BDividend YieldN/A2.49%4.01%4.02%P/E Ratio14.2121.3928.0720.12Price / Sales2.87275.08417.5199.64Price / Cash11.9641.6635.9658.29Price / Book3.228.188.555.81Net Income$145.49M-$55.10M$3.24B$258.18M7 Day Performance5.71%7.63%4.86%3.98%1 Month Performance16.57%21.73%13.00%14.81%1 Year Performance11.10%6.45%35.57%19.30% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.8453 of 5 stars$37.22+1.4%$51.00+37.0%+9.7%$2.14B$744.85M14.21200News CoveragePositive NewsAnalyst ForecastAnalyst RevisionROIVRoivant Sciences2.8125 of 5 stars$11.48+0.3%$16.50+43.7%+3.3%$7.80B$29.05M-45.92860Positive NewsLEGNLegend Biotech3.7062 of 5 stars$42.23+1.5%$73.33+73.7%-25.3%$7.76B$627.24M-71.582,609Positive NewsAnalyst RevisionELANElanco Animal Health2.0657 of 5 stars$14.67-0.8%$16.00+9.1%+17.0%$7.28B$4.44B19.829,000Analyst RevisionRGCRegencell Bioscience0.2408 of 5 stars$14.40-0.7%N/AN/A$7.17BN/A0.0010RVMDRevolution Medicines4.6208 of 5 stars$38.42+0.3%$68.91+79.4%-20.2%$7.16B$11.58M-9.61250Positive NewsGRFSGrifols3.3095 of 5 stars$10.00+0.6%$10.30+3.0%+22.6%$6.83B$7.21B8.5523,822Upcoming EarningsGap UpTGTXTG Therapeutics3.7379 of 5 stars$37.42-1.3%$43.80+17.0%+82.8%$5.94B$329M155.92290Positive NewsNUVLNuvalent3.3374 of 5 stars$82.46-1.1%$119.60+45.0%-0.6%$5.92BN/A-18.7840Analyst ForecastCRSPCRISPR Therapeutics1.7562 of 5 stars$65.33+0.3%$71.75+9.8%+17.2%$5.64B$37.31M-14.45460Analyst ForecastAnalyst RevisionGap UpHigh Trading VolumeRYTMRhythm Pharmaceuticals3.2721 of 5 stars$88.63-0.6%$91.93+3.7%+76.4%$5.64B$130.13M-31.54140 Related Companies and Tools Related Companies Roivant Sciences Alternatives Legend Biotech Alternatives Elanco Animal Health Alternatives Regencell Bioscience Alternatives Revolution Medicines Alternatives Grifols Alternatives TG Therapeutics Alternatives Nuvalent Alternatives CRISPR Therapeutics Alternatives Rhythm Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRMY) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRMY Stock Alerts